Advertisement
Screener

SUCAMPO PHARMACEUTICALS, INC. Forms 3, 4 and 5: Preferred Stock

SUCAMPO PHARMACEUTICALS, INC. Forms 3, 4 and 5: Preferred Stock

Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 6 rows, 6 shown. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.

  • 2007-08-07: Reporting owner Astellas Pharma Inc.; Form 4; Security Series A Convertible Preferred Stock; Transaction C Conversion of derivative security.
  • 2007-08-07: Reporting owner Ridgeway Capital Partners LTD; Form 4; Security Series A Convertible Preferred Stock; Transaction C Conversion of derivative security.
  • 2007-08-07: Reporting owner Mine Hidetoshi; Form 4; Security Series A Convertible Preferred Stock; Transaction C Conversion of derivative security.
  • 2007-08-02: Reporting owner Ridgeway Capital Partners LTD; Form 3; Security Series A Convertible Preferred Stock; Transaction Holding.
Transaction dateReporting ownerFormSecurityTransactionSharesPricePrice that dayFiling
2007-08-07Astellas Pharma Inc.
Other (Former 10% Owner)
4Series A Convertible Preferred Stock
Derivative · Direct
C Conversion of derivative security−1,253,750
0 owned after
no price filed2007-08-08
2007-08-07Ridgeway Capital Partners LTD
10% Owner
4Series A Convertible Preferred Stock
Derivative · Indirect · By OPE Limited Partnership 1
C Conversion of derivative security−922
0 owned after
no price filed2007-08-07
2007-08-07Mine Hidetoshi
Director, 10% Owner
4Series A Convertible Preferred Stock
Derivative · Indirect · By OPE Limited Partnership 1
C Conversion of derivative security−922
0 owned after
no price filed2007-08-07
2007-08-02
holding as of filing
Ridgeway Capital Partners LTD
10% Owner
3Series A Convertible Preferred Stock
Derivative · Indirect · By OPE Limited Partnership 1
Holdingno price filed2007-08-02
2007-08-02
holding as of filing
Mine Hidetoshi
Director, 10% Owner
3Series A Convertible Preferred Stock
Derivative · Indirect · By OPE Limited Partnership 1
Holdingno price filed2007-08-02
2007-08-02
holding as of filing
Astellas Pharma Inc.
10% Owner
3Series A Convertible Preferred Stock
Derivative · Direct
Holdingno price filed2007-08-02